Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Commercial Support

This activity is supported by educational grants from BeiGene, Ltd.

Advances in™: Recent Developments in Diagnosis and Treatment of Mantle Cell Lymphoma

Release Date: June 12, 2020
Expiration Date: June 12, 2021

Activity Overview

This online educational activity is designed to provide expert interpretation of new and emerging data on the treatment of mantle cell lymphoma, with a forward-looking perspective on how new and novel agents might impact clinical practice. The essentials of disease classification, prognosis, current and emerging treatment strategies, sequencing of therapies, and management of treatment-related toxicities will be presented in a multimedia format, including a series of video interviews with an expert thought leader integrated into text-based elements.

Acknowledgment of Commercial Support

This activity is supported by educational grants from BeiGene, Ltd.

Instructions for This Activity and Receiving Credit

  1. Complete the activity (including pre- and post-activity assessments).
  2. Answer the evaluation questions.
  3. Request credit using the drop-down menu.

You may immediately download your certificate.

Target Audience

This educational program is directed toward hematologists and medical oncologists interested in the treatment of mantle cell lymphoma (MCL). Other allied healthcare professionals involved in the treatment and management of patients with MCL, including pathologists, nurse practitioners, physician assistants, and nurses, will also be invited to participate.

Learning Objectives

Upon successful completion of this educational activity, you should be better prepared to:

  • Outline diagnostic and prognostic strategies to improve the outcomes of patients with mantle cell lymphoma
  • Select the best treatment strategies across different categories of therapy (ie, induction, maintenance, and relapsed mantle cell lymphoma) to provide the best care for patients with mantle cell lymphoma
  • Consider emerging therapies being tested for the treatment and management of patients with mantle cell lymphoma

Faculty, Staff, and Planners’ Disclosures

In accordance with ACCME Guidelines, PER® has identified and resolved all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.


Javier Munoz, MD, MS, FACP
Javier Munoz, MD, MS, FACP
Program Director, Lymphoma
Senior Associate Consultant, Division of Hematology and Medical Oncology
Mayo Clinic
Phoenix, AZ

Disclosures: Grant/Research Support: Celgene, Genentech, Incyte Corporation, Janssen, Kite Pharma, Millennium Pharmaceuticals, Pharmacyclics, Portola Pharmaceuticals, Seattle Genetics; Consultant: Alexion Pharmaceuticals, Bayer, BeiGene, Bristol Myers Squibb, Fosun Kite Biotechnology, Gilead/Kite Pharma, Innovent Biologics, Janssen, Juno/Celgene, Kyowa Kirin, Pfizer, Pharmacyclics, Seattle Genetics; Speaker’s Bureau: Acrotech Biopharma, AstraZeneca, Bayer, BeiGene, Celgene, Genentech/AbbVie, Gilead/Kite Pharma, Kyowa Kirin, Pharmacyclics/Janssen, Seattle Genetics, Verastem Oncology; Other Support: Kyowa Kirin, Seattle Genetics.

The staff Physicians' Education Resource®, LLC (PER®) have no relevant financial relationships with commercial interests to disclose.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.

Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
Filter By